Altretamine 50mg Capsule PCD Franchise in Ahmedabad

Oncology Medicine Supplier in Bangalore

Altretamine 50mg Capsule Distributor in Hyderabad

Cancer Care Capsule Franchise Opportunity in Jaipur

Oncology Drug Stockist in Mumbai
Altretamine Capsule Export & Manufacturing in Chandigarh

Home/Products /altretamine-50mg-capsule

Altramine 50 Capsule

Composition : Altretamine (50mg) Capsule

Dosage Form : Capsule

Packaging Type : Alu Strip

Packaging : 10*10

Price : ₹1/-

Altramine 50 Capsule contains Altretamine 50mg, an established oncology medicine primarily used for supportive therapy in ovarian cancer and certain other malignancies. Its mechanism helps inhibit cancer cell proliferation and supports overall chemotherapy management.

The capsule ensures consistent delivery and therapeutic effect, making it a reliable component of oncology treatment regimens. Its usage in combination with other anticancer therapies enhances efficacy and patient outcomes.

For suppliers and distributors, Altramine 50 Capsule is a high-value product in the oncology segment, with demand coming from hospitals, cancer specialty centers, and institutional buyers. Oncology medicines typically ensure stable and ongoing orders due to continuous treatment protocols.

Adding Altramine 50 to your portfolio allows partners to strengthen their oncology product range, increase market credibility in high-priority therapeutic areas, and secure consistent revenue from a premium prescription-driven segment.

Read More

About the Product

Altramine 50 Capsule contains Altretamine 50mg, an established oncology medicine primarily used for supportive therapy in ovarian cancer and certain other malignancies. Its mechanism helps inhibit cancer cell proliferation and supports overall chemotherapy management.

The capsule ensures consistent delivery and therapeutic effect, making it a reliable component of oncology treatment regimens. Its usage in combination with other anticancer therapies enhances efficacy and patient outcomes.

For suppliers and distributors, Altramine 50 Capsule is a high-value product in the oncology segment, with demand coming from hospitals, cancer specialty centers, and institutional buyers. Oncology medicines typically ensure stable and ongoing orders due to continuous treatment protocols.

Adding Altramine 50 to your portfolio allows partners to strengthen their oncology product range, increase market credibility in high-priority therapeutic areas, and secure consistent revenue from a premium prescription-driven segment.

Common side effects include nausea, vomiting, fatigue, loss of appetite, and mild gastrointestinal discomfort. Rare but serious effects may include bone marrow suppression, anemia, thrombocytopenia, peripheral neuropathy, and allergic reactions.

Altramine 50 Capsule is indicated for the treatment of advanced ovarian cancer, especially in patients who have shown resistance to or relapse after first-line chemotherapy. It helps slow disease progression and improve treatment outcomes.

Use only under strict medical supervision, preferably in oncology settings. Monitor blood counts regularly during treatment. Avoid pregnancy and use effective contraception. Follow prescribed dosage and do not self-administer.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation